Northwestern Mutual Wealth Management CO Biocryst Pharmaceuticals Inc Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 8,867 shares of BCRX stock, worth $83,261. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,867
Previous 527
1582.54%
Holding current value
$83,261
Previous $4,000
1550.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
167MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$206 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$187 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$111 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$85.3 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$76.5 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.75B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...